Holy Family Memorial | |
2300 Western Ave, Manitowoc, Wisconsin 54221 | |
(920) 320-2011 | |
Name | Holy Family Memorial |
---|---|
Type | Acute Care Hospital |
Location | 2300 Western Ave, Manitowoc, Wisconsin |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 520107 |
NPI Number | 1700998697 |
Organization Name | HOLY FAMILY MEMORIAL INC |
Doing Business As | FROEDTERT HOLY FAMILY MEMORIAL HOSPITAL |
Address | 2300 Western Ave, Manitowoc, WI 54220 |
Hospital Type | General Acute Care Hospital |
Phone Number | 920-320-2011 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by Caris Molecular Intelligence, this study represents the largest, multi-national analysis in a single laboratory setting of the main molecular anomalies in colorectal cancer.
Cyclacel Pharmaceuticals, Inc. announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of myelodysplastic syndromes (MDS) will be presented at a poster presentation during the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, on Saturday, December 4, 2010.
Hospitalized patients treated by physicians who order more or more expensive tests and procedures are just as likely to be readmitted or to die as patients treated by doctors who order fewer or less expensive tests, according to research led by Harvard Medical School and the Harvard T.H. Chan School of Public Health.
The U.S. Senate on Thursday passed a $105.9 billion war-funding bill that "includes $7.7 billion to prepare for pandemic flu," the Washington Post reports (Bacon, Washington Post, 6/19).
› Verified 1 days ago
NPI Number | 1972745958 |
Organization Name | HOLY FAMILY MEMORIAL INC |
Address | 1650 S 41st St, Manitowoc, WI 54220 |
Hospital Type | General Acute Care Hospital |
Phone Number | 920-320-3100 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by Caris Molecular Intelligence, this study represents the largest, multi-national analysis in a single laboratory setting of the main molecular anomalies in colorectal cancer.
Cyclacel Pharmaceuticals, Inc. announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of myelodysplastic syndromes (MDS) will be presented at a poster presentation during the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, on Saturday, December 4, 2010.
Hospitalized patients treated by physicians who order more or more expensive tests and procedures are just as likely to be readmitted or to die as patients treated by doctors who order fewer or less expensive tests, according to research led by Harvard Medical School and the Harvard T.H. Chan School of Public Health.
The U.S. Senate on Thursday passed a $105.9 billion war-funding bill that "includes $7.7 billion to prepare for pandemic flu," the Washington Post reports (Bacon, Washington Post, 6/19).
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by Caris Molecular Intelligence, this study represents the largest, multi-national analysis in a single laboratory setting of the main molecular anomalies in colorectal cancer.
Cyclacel Pharmaceuticals, Inc. announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of myelodysplastic syndromes (MDS) will be presented at a poster presentation during the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, on Saturday, December 4, 2010.
Hospitalized patients treated by physicians who order more or more expensive tests and procedures are just as likely to be readmitted or to die as patients treated by doctors who order fewer or less expensive tests, according to research led by Harvard Medical School and the Harvard T.H. Chan School of Public Health.
The U.S. Senate on Thursday passed a $105.9 billion war-funding bill that "includes $7.7 billion to prepare for pandemic flu," the Washington Post reports (Bacon, Washington Post, 6/19).
› Verified 1 days ago
Holy Family Memorial Acute Care Hospital Location: 2300 Western Ave, Manitowoc, Wisconsin 54221 Phone: (920) 320-2011 |